Can Gene-Edited immune cells tame Hard-to-Treat cancers?
Disease control
Not yet recruiting
This trial is testing an experimental therapy called CRG-150, which uses a patient's own immune cells that have been gene-edited to potentially fight cancer. The study includes adults with advanced HR-positive/HER2-negative breast cancer, triple-negative breast cancer, or prostat…
Phase: PHASE1, PHASE2 • Sponsor: CoRegen, Inc. • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC